Amid new warnings about a possible summer of terror, the U.S. government is preparing to spend $5.6 billion over a decade to coax pharmaceutical companies to develop drugs to fend off a biological or chemical attack.

By contrast, a single cholesterol drug — Lipitor — rakes in $9 billion in revenue each year.